Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Balance Sheet

GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Balance Sheet History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
EQUITY AND LIABILITIES
Share Capital ₹28 Cr₹28 Cr₹28 Cr₹28 Cr₹28 Cr
    Equity - Authorised ₹237 Cr₹237 Cr₹237 Cr₹237 Cr₹237 Cr
    Equity - Issued ₹28 Cr₹28 Cr₹28 Cr₹28 Cr₹28 Cr
    Equity Paid Up ₹28 Cr₹28 Cr₹28 Cr₹28 Cr₹28 Cr
    Equity Shares Forfeited -----
    Adjustments to Equity -----
    Preference Capital Paid Up -----
    Face Value ₹1.00₹1.00₹1.00₹1.00₹1.00
Share Warrants & Outstandings ₹34 Cr₹9.06 Cr₹18 Cr₹18 Cr₹16 Cr
Total Reserves ₹10,450 Cr₹8,812 Cr₹7,801 Cr₹9,428 Cr₹9,042 Cr
    Securities Premium ₹1,687 Cr₹1,687 Cr₹1,687 Cr₹1,685 Cr₹1,685 Cr
    Capital Reserves ₹0.10 Cr₹0.10 Cr₹0.10 Cr₹0.10 Cr₹0.10 Cr
    Profit & Loss Account Balance ₹9,882 Cr₹8,799 Cr₹7,870 Cr₹9,457 Cr₹9,211 Cr
    General Reserves ₹116 Cr₹115 Cr₹146 Cr₹146 Cr₹146 Cr
    Other Reserves ₹-1,235 Cr₹-1,788 Cr₹-1,901 Cr₹-1,860 Cr₹-2,000 Cr
Reserve excluding Revaluation Reserve ₹10,450 Cr₹8,812 Cr₹7,801 Cr₹9,428 Cr₹9,042 Cr
Revaluation reserve -----
Shareholder's Funds ₹10,512 Cr₹8,849 Cr₹7,848 Cr₹9,474 Cr₹9,087 Cr
Minority Interest ₹-0.32 Cr₹-0.37 Cr₹-0.38 Cr₹365 Cr₹351 Cr
Long-Term Borrowings -----
Secured Loans -----
    Non Convertible Debentures -----
    Converible Debentures & Bonds -----
    Packing Credit - Bank -----
    Inter Corporate & Security Deposit -----
    Term Loans - Banks -----
    Term Loans - Institutions -----
    Other Secured -----
Unsecured Loans -₹513 Cr-₹3,852 Cr₹2,572 Cr
    Fixed Deposits - Public -----
    Loans and advances from subsidiaries -----
    Inter Corporate Deposits (Unsecured) -----
    Foreign Currency Convertible Notes -----
    Long Term Loan in Foreign Currency --₹157 Cr₹2,806 Cr₹2,572 Cr
    Loans - Banks -₹513 Cr-₹1,191 Cr-
    Loans - Govt. -----
    Loans - Others -----
    Other Unsecured Loan --₹-157 Cr₹-146 Cr-
Deferred Tax Assets / Liabilities ₹-1,245 Cr₹-1,066 Cr₹-1,049 Cr₹-1,805 Cr₹-1,655 Cr
    Deferred Tax Assets ₹2,231 Cr₹1,323 Cr₹1,432 Cr₹2,046 Cr₹1,938 Cr
    Deferred Tax Liability ₹985 Cr₹257 Cr₹383 Cr₹240 Cr₹283 Cr
Other Long Term Liabilities ₹2,842 Cr₹662 Cr₹692 Cr₹575 Cr₹352 Cr
Long Term Trade Payables -----
Long Term Provisions ₹177 Cr----
Total Non-Current Liabilities ₹1,773 Cr₹109 Cr₹-357 Cr₹2,621 Cr₹1,270 Cr
Current Liabilities -----
Trade Payables ₹3,744 Cr₹3,051 Cr₹2,536 Cr₹2,000 Cr₹2,289 Cr
    Sundry Creditors ₹3,744 Cr₹3,051 Cr₹2,536 Cr₹2,000 Cr₹2,289 Cr
    Acceptances -----
    Due to Subsidiaries- Trade Payables -----
Other Current Liabilities ₹1,468 Cr₹436 Cr₹1,517 Cr₹1,605 Cr₹1,446 Cr
    Bank Overdraft / Short term credit -----
    Advances received from customers ₹675 Cr₹10 Cr---
    Interest Accrued But Not Due ₹0.26 Cr₹3.34 Cr₹4.40 Cr₹43 Cr₹14 Cr
    Share Application Money -----
    Current maturity of Debentures & Bonds -----
    Current maturity - Others -----
    Other Liabilities ₹793 Cr₹423 Cr₹1,513 Cr₹1,562 Cr₹1,433 Cr
Short Term Borrowings -₹1,681 Cr₹833 Cr₹350 Cr₹370 Cr
    Secured ST Loans repayable on Demands -₹299 Cr---
    Working Capital Loans- Sec -₹299 Cr---
    Buyers Credits - Unsec -----
    Commercial Borrowings- Unsec -----
    Other Unsecured Loans -₹1,084 Cr₹833 Cr₹350 Cr₹370 Cr
Short Term Provisions ₹1,165 Cr₹798 Cr₹932 Cr₹591 Cr₹585 Cr
    Proposed Equity Dividend -----
    Provision for Corporate Dividend Tax -----
    Provision for Tax ₹95 Cr₹28 Cr₹291 Cr₹98 Cr₹93 Cr
    Provision for post retirement benefits -----
    Preference Dividend -----
    Other Provisions ₹1,070 Cr₹770 Cr₹641 Cr₹492 Cr₹491 Cr
Total Current Liabilities ₹6,376 Cr₹5,967 Cr₹5,819 Cr₹4,546 Cr₹4,689 Cr
Total Liabilities ₹18,661 Cr₹14,925 Cr₹13,309 Cr₹17,566 Cr₹15,397 Cr
ASSETS
Gross Block ₹12,072 Cr₹10,365 Cr₹9,620 Cr₹10,360 Cr₹10,213 Cr
Less: Accumulated Depreciation ₹6,157 Cr₹5,878 Cr₹5,409 Cr₹4,938 Cr₹4,326 Cr
Less: Impairment of Assets -----
Net Block ₹5,915 Cr₹4,487 Cr₹4,210 Cr₹5,422 Cr₹5,887 Cr
Lease Adjustment A/c -----
Capital Work in Progress ₹428 Cr₹542 Cr₹419 Cr₹1,066 Cr₹921 Cr
Non Current Investments ₹42 Cr₹56 Cr₹790 Cr₹45 Cr₹50 Cr
Long Term Investment ₹42 Cr₹56 Cr₹790 Cr₹45 Cr₹50 Cr
    Quoted ₹0.13 Cr₹0.11 Cr₹745 Cr₹0.07 Cr₹0.05 Cr
    Unquoted ₹42 Cr₹56 Cr₹45 Cr₹45 Cr₹50 Cr
Long Term Loans & Advances ₹493 Cr₹243 Cr₹212 Cr₹181 Cr₹161 Cr
Other Non Current Assets ₹2.86 Cr₹9.23 Cr₹7.42 Cr₹3.46 Cr₹6.70 Cr
Total Non-Current Assets ₹7,362 Cr₹5,630 Cr₹5,881 Cr₹6,840 Cr₹7,115 Cr
Current Assets Loans & Advances -----
Currents Investments -----
    Quoted -----
    Unquoted -----
Inventories ₹3,431 Cr₹3,029 Cr₹2,513 Cr₹2,374 Cr₹2,500 Cr
    Raw Materials ₹709 Cr₹832 Cr₹580 Cr₹649 Cr₹703 Cr
    Work-in Progress ₹137 Cr₹115 Cr₹103 Cr₹84 Cr₹402 Cr
    Finished Goods ₹1,766 Cr₹1,397 Cr₹1,193 Cr₹1,020 Cr₹846 Cr
    Packing Materials ₹349 Cr₹384 Cr₹314 Cr₹298 Cr₹269 Cr
    Stores  and Spare ₹39 Cr₹89 Cr₹111 Cr₹114 Cr₹104 Cr
    Other Inventory ₹431 Cr₹211 Cr₹213 Cr₹209 Cr₹174 Cr
Sundry Debtors ₹4,963 Cr₹3,342 Cr₹1,858 Cr₹3,665 Cr₹3,101 Cr
    Debtors more than Six months ₹1,086 Cr₹621 Cr₹396 Cr₹363 Cr₹302 Cr
    Debtors Others ₹4,484 Cr₹2,854 Cr₹1,593 Cr₹3,443 Cr₹2,929 Cr
Cash and Bank ₹1,176 Cr₹1,705 Cr₹1,659 Cr₹1,160 Cr₹1,412 Cr
    Cash in hand ₹0.87 Cr₹1.07 Cr₹0.98 Cr₹1.04 Cr₹1.69 Cr
    Balances at Bank ₹1,175 Cr₹1,704 Cr₹1,658 Cr₹1,159 Cr₹1,410 Cr
    Other cash and bank balances -----
Other Current Assets ₹308 Cr₹145 Cr₹178 Cr₹317 Cr₹297 Cr
    Interest accrued on Investments -----
    Interest accrued on Debentures -----
    Deposits with Government -----
    Interest accrued and or due on loans -----
    Prepaid Expenses ₹100 Cr₹105 Cr₹27 Cr₹227 Cr₹220 Cr
    Other current_assets ₹208 Cr₹40 Cr₹152 Cr₹89 Cr₹78 Cr
Short Term Loans and Advances ₹1,421 Cr₹1,075 Cr₹1,219 Cr₹908 Cr₹972 Cr
    Advances recoverable in cash or in kind ₹712 Cr₹521 Cr₹526 Cr₹382 Cr₹457 Cr
    Advance income tax and TDS -----
    Amounts due from directors -----
    Due From Subsidiaries -----
    Inter corporate deposits -----
    Corporate Deposits -----
    Other Loans & Advances ₹709 Cr₹554 Cr₹693 Cr₹526 Cr₹516 Cr
Total Current Assets ₹11,300 Cr₹9,295 Cr₹7,428 Cr₹8,424 Cr₹8,282 Cr
Net Current Assets (Including Current Investments) ₹4,923 Cr₹3,328 Cr₹1,609 Cr₹3,877 Cr₹3,593 Cr
Miscellaneous Expenses not written off -----
Total Assets ₹18,661 Cr₹14,925 Cr₹13,309 Cr₹17,566 Cr₹15,397 Cr
Contingent Liabilities ₹788 Cr₹800 Cr₹1,063 Cr₹337 Cr₹361 Cr
Total Debt -₹2,194 Cr₹991 Cr₹4,348 Cr₹3,670 Cr
Book Value -313.28277.46335.13321.45
Adjusted Book Value 371.30313.28277.46335.13321.45

Compare Balance Sheet of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹66,034.8 Cr 1.9% 2.3% 11.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹461,848.0 Cr -1.4% -1.3% 21.5% Stock Analytics
DIVIS LABORATORIES ₹225,648.0 Cr 2.7% 16.1% 38.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹184,109.0 Cr -1.5% -3.3% 35.6% Stock Analytics
CIPLA ₹117,139.0 Cr -0.7% 1.4% -2% Stock Analytics
DR REDDYS LABORATORIES ₹100,328.0 Cr 3.9% -1.8% 0.4% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1.9%

2.3%

11.2%

SENSEX

-0.6%

1.1%

-3.2%


You may also like the below Video Courses